Literature DB >> 23080035

Weak detrusor contractility correlates with motor disorders in Parkinson's disease.

Keiichiro Terayama1, Ryuji Sakakibara, Akihiro Ogawa, Hiroyuki Haruta, Takashi Akiba, Takeki Nagao, Osamu Takahashi, Megumi Sugiyama, Akihiko Tateno, Fuyuki Tateno, Masashi Yano, Masahiko Kishi, Yohei Tsuyusaki, Tomoyuki Uchiyama, Tatsuya Yamamoto.   

Abstract

Limited attention has been paid to the relationship between urinary symptoms or urodynamic findings and motor disorders in Parkinson's disease (PD). We aimed to correlate pressure-flow urodynamic parameters with video-gait analysis parameters in PD. We recruited 41 patients with PD (25 men and 16 women; age, 70.6 ± 8.5 years; H &amp; Y motor grading: 2 [range, 1-3]; disease duration: 4 years [range, 1-7]; taking levodopa 300 mg/day [range, 100-400]). All patients underwent pressure-flow urodynamics (parameters: first sensation, bladder capacity, detrusor overactivity [noted in 24 patients], and Watts factor [WF]) and video-gait analysis (parameters: time and number of strides for 5-m gait [simple task] and time for timed up and go [complex task]). Statistical analysis was made by Mann-Whitney's U-test for analyzing the relation between detrusor overactivity and gait as well as Spearman's rank-correlation coefficient test for analyzing the relation between the remaining parameters and gait. We found no relation between filling-phase urodynamics (detrusor overactivity, first sensation, and bladder capacity) and video-gait analysis parameters. By contrast, we found a significant relation between voiding-phase urodynamics (WF, reflecting detrusor power) and all three video-gait analysis parameters (reflecting lower-half bradykinesia and loss of postural reflex) in our PD patients (P < 0.01). The close relation between the WF and motor disorders in the present study suggests that, though clinically mild, a weak detrusor in PD might have a central origin. We should follow postvoid residual volume carefully in PD patients with advanced gait disorder, because postvoid residual volume might increase in such patients.
Copyright © 2012 Movement Disorder Society.

Entities:  

Mesh:

Year:  2012        PMID: 23080035     DOI: 10.1002/mds.25225

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  10 in total

Review 1.  Urological dysfunction in synucleinopathies: epidemiology, pathophysiology and management.

Authors:  Ryuji Sakakibara; Fuyuki Tateno; Tatsuya Yamamoto; Tomoyuki Uchiyama; Tomonori Yamanishi
Journal:  Clin Auton Res       Date:  2017-11-09       Impact factor: 4.435

2.  Underactive and overactive bladders are related to motor function and quality of life in Parkinson's disease.

Authors:  Zhi Liu; Tomoyuki Uchiyama; Ryuji Sakakibara; Tatsuya Yamamoto
Journal:  Int Urol Nephrol       Date:  2015-03-20       Impact factor: 2.370

Review 3.  OnabotulinumtoxinA Treatment for Overactive Bladder in the Elderly: Practical Points and Future Prospects.

Authors:  Hann-Chorng Kuo
Journal:  Drugs Aging       Date:  2016-01       Impact factor: 3.923

4.  Does Depression Contribute to the Bladder and Bowel Complaint in Parkinson's Disease Patients?

Authors:  Ryuji Sakakibara; Tsuyoshi Ogata; Yosuke Aiba; Fuyuki Tateno; Tomoyuki Uchiyama; Tatsuya Yamamoto
Journal:  Mov Disord Clin Pract       Date:  2020-12-27

5.  Efficacy and safety of intravesical onabotulinumtoxinA injection on elderly patients with chronic central nervous system lesions and overactive bladder.

Authors:  Yuan-Hong Jiang; Chun-Hou Liao; Dong-Ling Tang; Hann-Chorng Kuo
Journal:  PLoS One       Date:  2014-08-22       Impact factor: 3.240

6.  The voiding efficiency in rat models with dopaminergic brain lesions induced through unilateral and bilateral intrastriatal injections.

Authors:  Chellappan Praveen Rajneesh; Jian-Chiun Liou; Tsung-Hsun Hsieh; Jia-Hong Lin; Chih-Wei Peng
Journal:  PLoS One       Date:  2020-12-03       Impact factor: 3.240

7.  Prevalence of lower urinary tract symptoms, urinary incontinence and retention in Parkinson's disease: A systematic review and meta-analysis.

Authors:  Fang-Fei Li; Yu-Sha Cui; Rui Yan; Shuang-Shuang Cao; Tao Feng
Journal:  Front Aging Neurosci       Date:  2022-09-12       Impact factor: 5.702

8.  Investigation of Urination Disorder in Parkinson's disease.

Authors:  Li-Mei Zhang; Xu-Ping Zhang
Journal:  Chin Med J (Engl)       Date:  2015-11-05       Impact factor: 2.628

Review 9.  Intravesical OnabotulinumtoxinA Injection for Overactive Bladder Patients with Frailty, Medical Comorbidities or Prior Lower Urinary Tract Surgery.

Authors:  Chun-Hou Liao; Chung-Cheng Wang; Yuan-Hong Jiang
Journal:  Toxins (Basel)       Date:  2016-03-25       Impact factor: 4.546

10.  Comparative study of the maximum Watts factor and Schafer contractility grade, bladder contractility index in male patients with lower urinary tract symptoms.

Authors:  Dandan Liu; Min Chen; Xiaomin Han; Ying Li
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.